Literature DB >> 21994520

Cerebral salt wasting syndrome in a patient affected of spontaneous frontoparietal subdural haematoma.

Mariaina Cerdá-Esteve1, Mariona Badia, Javier Trujillano, Cecília Vilanova, Javier Maravall, Dídac Mauricio.   

Abstract

Ever since cerebral salt wasting syndrome (CSW) was first described in 1950, there have been debates over its existence and whether it has an important place in the differential diagnosis of hyponatraemia. We report the case of a neurosurgical patient with sustained hyponatraemia and abnormally high sodium loss in the urine, with signs of fluid volume depletion. Hyponatraemia was not corrected after an intravenous infusion of saline solution. Stable concentrations of blood sodium above 130 mmol/l were achieved with the administration of 100 mg of hydrocortisone daily, with an ensuing reduction in sodium elimination through the urine.

Entities:  

Year:  2009        PMID: 21994520      PMCID: PMC3027907          DOI: 10.1136/bcr.09.2008.0966

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

1.  Early hyponatraemia after pituitary surgery: cerebral salt-wasting syndrome.

Authors:  R Guerrero; A Pumar; A Soto; M A Pomares; S Palma; M A Mangas; A Leal; F Villamil
Journal:  Eur J Endocrinol       Date:  2007-06       Impact factor: 6.664

Review 2.  Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study.

Authors:  J C Ayus; R K Krothapalli; A I Arieff
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

3.  Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage.

Authors:  T Mori; Y Katayama; T Kawamata; T Hirayama
Journal:  J Neurosurg       Date:  1999-12       Impact factor: 5.115

4.  Cerebral salt wasting syndrome in brain injury patients: a potential cause of hyponatremia.

Authors:  R D Zafonte; N R Mann
Journal:  Arch Phys Med Rehabil       Date:  1997-05       Impact factor: 3.966

5.  Syndromes related to sodium and arginine vasopressin alterations in post-operative neurosurgery.

Authors:  Ana P D Cardoso; Desanka Dragosavac; Sebastião Araújo; Antonio L E Falcão; Renato G G Terzi; Margaret de Castro; Fabiana G Marcondes; Taís G Melo; Rosmari A R A Oliveira; Eliana A Cintra
Journal:  Arq Neuropsiquiatr       Date:  2007-09       Impact factor: 1.420

6.  Hyponatremia in neurological patients: cerebral salt wasting versus inappropriate antidiuretic hormone secretion.

Authors:  Serge Brimioulle; Carlos Orellana-Jimenez; Adel Aminian; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2007-10-19       Impact factor: 17.440

Review 7.  Cerebral salt wasting syndrome: review.

Authors:  M Cerdà-Esteve; E Cuadrado-Godia; J J Chillaron; C Pont-Sunyer; G Cucurella; M Fernández; A Goday; J F Cano-Pérez; A Rodríguez-Campello; J Roquer
Journal:  Eur J Intern Med       Date:  2008-03-07       Impact factor: 4.487

8.  A randomized controlled trial of hydrocortisone against hyponatremia in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Yoichi Katayama; Jo Haraoka; Hidehiro Hirabayashi; Tatsuro Kawamata; Keiji Kawamoto; Takao Kitahara; Jun Kojima; Toshihiko Kuroiwa; Tatsuro Mori; Nobuhiro Moro; Izumi Nagata; Akira Ogawa; Kikuo Ohno; Yoshikatsu Seiki; Yoshiaki Shiokawa; Akira Teramoto; Teiji Tominaga; Toshiki Yoshimine
Journal:  Stroke       Date:  2007-06-21       Impact factor: 7.914

9.  Mineralocorticoid deficiency in post-operative cerebral salt wasting.

Authors:  Dimitrios T Papadimitriou; Anne Spiteri; Anne Pagnier; Monique Bayle; Mariana Bohns Mischalowski; Guylhène Bourdat; Jean-Guy Passagia; Dominique Plantaz; Michel Bost; Philippe E Garnier
Journal:  J Pediatr Endocrinol Metab       Date:  2007-10       Impact factor: 1.634

Review 10.  Disturbances of sodium in critically ill adult neurologic patients: a clinical review.

Authors:  Martin Tisdall; Matthew Crocker; Jonathan Watkiss; Martin Smith
Journal:  J Neurosurg Anesthesiol       Date:  2006-01       Impact factor: 3.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.